DP Clinical 31 Miles Walking Challenge
ROCKVILLE, MD – November 7, 2023 – THANK YOU to everyone who participated in our 31 Miles in 31 Days Walking Challenge. DPC had an amazing showing of support for Parkinson’s Research. Here are the results: Total # of Walkers: 21 Total # of Miles Walked: 694.10 694.10 miles equates to 43,978,176 steps Well done, DPC.
DP Clinical Facilitating Roundtable at OCT New England
ROCKVILLE, MD – October 12, 2023 – DP Clinical will be hosting and facilitating an interactive roundtable discussion at the upcoming Outsourcing in Clinical Trials New England with Q&A on topics such as: CRO Selection Process Best Practices for Writing an RFP Feasibility – How Much Validation is Enough? Accountability, Governance, and Strategic Guidance Differences Between Small [...]
DP Clinical Welcomes Timothy Urschel as Vice President, Regulatory Affairs/Quality Assurance
ROCKVILLE, MD – June 10, 2021 – DP Clinical, Inc., a Contract Research Organization (CRO) specializing in dermatology, infectious disease, neuroscience, oncology, and ophthalmology Phase I-III clinical programs; continues its growth with the addition of Tim Urschel as Vice President, Regulatory Affairs/Quality Assurance. Mr. Urschel joined the DP Clinical team in October 2020 and brings [...]
DP Clinical Announces Database Lock of its First COVID-19 Clinical Trial ROCKVILLE, MD
ROCKVILLE, MD – February 19, 2021 – DP Clinical, Inc., a privately held Contract Research Organization (CRO), announced the database lock of its first COVID-19 clinical trial. Taking place the United States, the goal of the study was to determine a suitable dosage of a drug candidate for the treatment of severe acute respiratory syndrome-related [...]
DP Clinical Inaugural Member of the North American Spinal Cord Injury Consortium
The North American Spinal Cord Injury Consortium (NASCIC) has the mission to bring about unified achievements in research, care, and policy by fostering collaborative efforts across the spinal cord injury community. DP Clinical is an inaugural member of this important organization that brings together like-minded organizations, individuals, and groups to improve research, care, and policies [...]
DP Clinical Leads Critical Aspect of SCI Research
Michele Towle, from DP Clinical, is the Chair of the American Spinal Cord Injury Association’s (ASIA) Clinical Trial Training Program Committee for International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) Training. This new program will allow Sponsors and others to access formal ISNCSCI training through ASIA. Under Ms. Towle’s leadership, the team has [...]
DP Clinical Serves on ASIA’s Autonomic Standards Committee and Membership Committee
James Hamer from DP Clinical is a member of the American Spinal Injury Association’s (ASIA) Autonomic Standards Committee. This Committee is responsible for overseeing the development of new standards documents related to spinal cord injury as well as continuous review and improvement of the existing ASIA documents on neurological and autonomic standards. The Committee is [...]
2019 North American Spinal Cord Injury Consortium (NASCIC)
2019 North American Spinal Cord Injury Consortium (NASCIC) This extraordinary event will bring together delegates from members living with SCI, member organizations and advisory stakeholders. October 2019 DP Clinical is a proud Inaugural Partner Member of NASCIC
DP Clinical Assistant Director, Spinal Cord Injury Program, Elected to Board of U2FP
Michele Towle, Assistant Director, Spinal Cord Injury Program, at DP Clinical has been elected to the Board of Directors for Unite 2 Fight Paralysis (U2FP) and will serve a three-year term. U2FP was founded in 2005 by three women living with paralysis as either spinal cord injury survivors or family members. U2FP is committed to [...]